Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Sell
1,657
-296
-15% -$74.6K 0.17% 85
2026
Q1
$473K Sell
1,953
-83
-4% -$22.5K 0.19% 74
2025
Q4
$603K Sell
2,036
-222
-10% -$66.5K 0.25% 59
2025
Q3
$637K Buy
2,258
+259
+13% +$67.8K 0.28% 54
2025
Q2
$589K Sell
1,999
-129
-6% -$33.2K 0.28% 50
2025
Q1
$529K Buy
2,128
+29
+1% +$7.09K 0.28% 49
2024
Q4
$461K Sell
2,099
-114
-5% -$25.4K 0.24% 51
2024
Q3
$489K Buy
2,213
+484
+28% +$94.9K 0.27% 49
2024
Q2
$299K Buy
1,729
+51
+3% +$8.86K 0.17% 70
2024
Q1
$320K Sell
1,678
-12
-0.7% -$2.19K 0.19% 66
2023
Q4
$276K Sell
1,690
-2,359
-58% -$356K 0.18% 73
2023
Q3
$568K Buy
4,049
+1,302
+47% +$185K 0.41% 49
2023
Q2
$368K Sell
2,747
-217
-7% -$28K 0.25% 66
2023
Q1
$389K Buy
2,964
+947
+47% +$127K 0.28% 63
2022
Q4
$284K Buy
2,017
+118
+6% +$16.3K 0.22% 78
2022
Q3
$224K Buy
1,899
+12
+0.6% +$1.57K 0.19% 86
2022
Q2
$266K Buy
+1,887
New +$255K 0.23% 81

Other funds holding IBM

MRA Advisory Group's IBM Position: Q2 2026 in Review

MRA Advisory Group reduced its IBM (IBM) stake by 15% in Q2 2026, selling an estimated $74.6K and leaving 1,657 shares worth $466K. The position accounts for 0.17% of the portfolio, ranked #85.

MRA Advisory Group first reported a position in IBM in Q2 2022 and has held it in 17 quarters since. The position peaked at $637K in Q3 2025. 1,250 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • MRA Advisory Group held 1,657 shares of IBM worth $466K as of Q2 2026.
  • MRA Advisory Group sold 296 IBM shares in Q2 2026, an estimated $74.6K.
  • IBM made up 0.17% of MRA Advisory Group's portfolio in Q2 2026, its #85 holding.
  • MRA Advisory Group first reported a position in IBM in Q2 2022 and has held it in 17 quarters since.
  • MRA Advisory Group's IBM position peaked at $637K in Q3 2025.
  • 1,250 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.